VivoSeq
Psychiatry

Marijuana

0

Pipeline Programs

2

Active Trials

0

Companies Involved

Marijuana is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

26

clinical trials

Completed24 · 92%
Not yet recruiting2 · 8%

Trial Activity

26 trials

Marijuana Effects on Simulated Driving Performance
Completed··Phase 1·NCT03699540·10 enrolled
Behavioral Economic Analysis of Demand for Marijuana
Completed··Phase 2·NCT03518567·133 enrolled
Influence of Edible Marijuana on Endurance Exercise Performance
Completed··Phase 1·NCT05192239·17 enrolled
Baclofen Effects on Marijuana Dependence
Completed·UUniversity of Pennsylvania·Phase 2·NCT02011516·47 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)